Dr Reddy's Laboratories Q1 Results FY26: Q1 PAT Jumps 1.85% to ₹1,418.10 crore; Revenue Surged 11.38% YoY

Dr Reddy's Laboratories Q1 Results 2025: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹8,572.10	₹7,696.10
Profit Before Tax (PBT)	₹2,463.90	₹2,317.10
Profit After Tax (PAT)	₹1,418.10	₹1,392.40

(Figures in crore)

Dr Reddy's Laboratories Q1 Results 2025: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹7,809.50	₹5,841.20
Profit Before Tax (PBT)	₹4,235.30	₹2,170.80
Profit After Tax (PAT)	₹2,961.20	₹1,417.20

(Figures in crore)

Dr Reddy's Laboratories Q1 Results 2026 Highlights – (Q1 vs FY25)

• Dr Reddy's Laboratories clocked Q1 FY26 consolidated revenue of ₹8,572.10 crores vs ₹7,696.10 crores. 
• On the profit front, Dr Reddy's Laboratories earned a consolidated PAT of ₹1,418.10 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹1,392.40 crores. 
• Consolidated PAT is up for the first quarter of FY26, was 1.85% YoY, and revenue gain was 11.38% YoY. 
• As per the standalone figures, quarterly PAT of Dr Reddy's Laboratories is up 108.95% and revenue has grown by 33.70% YoY.

Dr Reddy's Laboratories Share Price Performance

On the opening bell of 24th July 2025, the shares of Dr Reddy's Laboratories opened at ₹1,261.10.00 per share. However, the initial gains are sustained as of now, and Dr Reddy's Laboratories shares are trading at ₹1,277.50 per share, higher than their opening price. 

Considering the long-term performance, Dr Reddy's Laboratories shares have yielded close to -6.34% returns in the past 1-year, and 5-year returns stand at 57.17%. Over the maximum timeframe, the Dr Reddy's Laboratories share provided 25,150.99% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Dr Reddy's Laboratories shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Wipro Q1 Results FY26: Q1 PAT Soars 10.90 % to ₹3,330.40 crore; Revenue Rose 0.78% YoY

Recent Articles

Coforge Q1 Results FY26: Q1 PAT Jumps 138.29% to ₹317.40 crore; Revenue Surged 56.49% YoY

Bikaji Foods Q1 Results FY26: Q1 PAT Jumps 2.80% to ₹59.90 crore; Revenue Surged 14.18% YoY

Brigade Hotel Ventures IPO GMP: Day 1 IPO Live Updates

Force Motors Q1 Results FY26: Q1 PAT Jumps 52.40% to ₹176.33 crore; Revenue Surged 21.88% YoY

Aditya Birla Real Estate Q1 Results FY26: Q1 PAT Drops 427.38% to -₹25.47 crore; Revenue Plunged 58.80% YoY

SRF Q1 Results FY26: Q1 PAT Jumps 71.41% to ₹432.32 crore; Revenue Surged 10.23% YoY

Infosys Q1 Results FY26: Q1 PAT Jumps 8.68% to ₹6,921.00 crore; Revenue Surged 7.54% YoY

Shanti Gold IPO GMP & Review: Apply or Avoid?

UBL Q1 Results FY26: Q1 PAT Jumps 5.95% to ₹183.87 crore; Revenue plunged 7.41% YoY

Best Defence Penny Stocks For Higher Growth in 2025